Aytu Biopharma Inc (AYTU) Stock Price, Quote & News

Company Profile

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 720 437 6580

Website: aytubio.com

Address:

Denver Corporate Center III, Suite 920 7900 East Union Avenue, Denver, United States

Ironman96 Oct. 25 at 4:17 PM

$AYTU

0 · Reply

Fibonacci5 Oct. 25 at 9:50 AM

$AYTU

0 · Reply

WaspofWallStreet Oct. 23 at 4:14 PM

$AYTU ay pee u

0 · Reply

Henry20feb_ Oct. 23 at 7:26 AM

$AYTU "Patience is a form of trust because it involves a deep-seated belief that things will work out as they should, even when you can't see the outcome. Instead of passive waiting, it is an active and hopeful expectation that the process, a relationship, or a higher power is working in your favor and that your goals will be achieved in their own time. This trust allows for a sense of peace and calm while navigating uncertainty." Source: AI 😇 Hallelujah Brothers and Sisters

2 · Reply

Chachix Oct. 22 at 8:59 PM

$AYTU This Bitch, Dishbrow-Mintz, ain’t in Jail? Still trading son a Hair Paint Scam Pharma company? After the Youge’’ Success with The Healight, we have another Trying Pump on A SCAM Company amd a Criminal CEO that have Stolen Investor’s Savings and Scam Even The President of the Inited States of America with The Healight on Covid Times!!!Hope you are getting Nailed, Dishbrow!!! AYTU, S C A M Since 2021!!!

0 · Reply

Alain_Simard Oct. 22 at 4:29 PM

$AYTU what ever happened to that cup and handle formation???? Lololol

0 · Reply

Henry20feb_ Oct. 22 at 7:35 AM

$AYTU "Wake Up Litlle Susie!" 🥵

0 · Reply

Butter_nutz Oct. 21 at 7:24 PM

$AYTU Corrupt management... dilution monster.... reverse split machine

0 · Reply

WaspofWallStreet Oct. 21 at 2:48 PM

$AYTU reduced position yesterday with a fill at 2.39.

0 · Reply

Henry20feb_ Oct. 19 at 2:57 PM

$AYTU My posts are not investment advice and may differ from the actual facts!

0 · Reply

Aytu BioPharma to Present at Upcoming October 2025 Conferences

Sep 24, 2025, 4:15 PM EDT - 4 weeks ago

Aytu BioPharma to Present at Upcoming September 2025 Conferences

Sep 23, 2025, 9:43 PM EDT - 4 weeks ago

Aytu BioPharma, Inc. (AYTU) Q4 2025 Earnings Call Transcript

Sep 23, 2025, 4:05 PM EDT - 4 weeks ago

Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)

Sep 16, 2025, 4:05 PM EDT - 5 weeks ago

Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025

Jun 25, 2025, 8:00 AM EDT - 4 months ago

Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)

Jun 23, 2025, 8:00 AM EDT - 4 months ago

Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)

Jun 9, 2025, 4:30 PM EDT - 4 months ago

Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan

Jun 6, 2025, 8:01 AM EDT - 5 months ago

Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock

Jun 6, 2025, 8:00 AM EDT - 5 months ago

Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States

May 14, 2025, 8:29 PM EDT - 5 months ago

Aytu BioPharma, Inc. (Aytu ) Q3 2025 Earnings Call Transcript

May 14, 2025, 4:05 PM EDT - 5 months ago

Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results

May 7, 2025, 4:15 PM EDT - 6 months ago

Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025

Apr 21, 2025, 4:05 PM EDT - 6 months ago

Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Feb 12, 2025, 6:27 PM EST - 9 months ago

Aytu BioPharma, Inc. (AYTU) Q2 2025 Earnings Call Transcript

Feb 12, 2025, 4:03 PM EST - 9 months ago

Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results

Feb 5, 2025, 5:50 PM EST - 9 months ago

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

Jan 6, 2025, 9:00 AM EST - 10 months ago

Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Dec 3, 2024, 11:45 PM EST - 11 months ago

Aytu BioPharma Disclosure Notification

Nov 22, 2024, 9:00 AM EST - 1 year ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

Nov 13, 2024, 7:25 PM EST - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript

Nov 13, 2024, 4:05 PM EST - 1 year ago

Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results

Nov 6, 2024, 5:20 PM EST - 1 year ago

Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024

Oct 14, 2024, 4:15 PM EDT - 1 year ago

Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 1, 2024, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada

Sep 26, 2024, 6:51 PM EDT - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q4 2024 Earnings Call Transcript

Sep 26, 2024, 4:15 PM EDT - 1 year ago

Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

Sep 19, 2024, 5:30 PM EDT - 1 year ago

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024

Aug 8, 2024, 5:20 PM EDT - 1 year ago

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

Aug 6, 2024, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

Jun 18, 2024, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

May 15, 2024, 8:28 PM EDT - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q3 2024 Earnings Call Transcript

May 15, 2024, 4:05 PM EDT - 1 year ago

Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results

May 8, 2024, 4:15 PM EDT - 1 year ago

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

Apr 3, 2024, 9:00 AM EDT - 1 year ago

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024

Feb 14, 2024, 10:52 PM EST - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript

Feb 14, 2024, 4:05 PM EST - 1 year ago

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Feb 7, 2024, 4:15 PM EST - 1 year ago

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

Jan 23, 2024, 9:00 AM EST - 1 year ago

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Nov 30, 2023, 8:00 AM EST - 2 years ago

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

Nov 14, 2023, 7:30 PM EST - 2 years ago

Aytu BioPharma, Inc. (AYTU) Q1 2024 Earnings Call Transcript

Nov 14, 2023, 4:05 PM EST - 2 years ago

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Nov 8, 2023, 8:30 AM EST - 2 years ago

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

Nov 7, 2023, 4:15 PM EST - 2 years ago

Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023

Oct 26, 2023, 8:00 AM EDT - 2 years ago

Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Oct 9, 2023, 4:15 PM EDT - 2 years ago

Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023

Sep 27, 2023, 7:01 PM EDT - 2 years ago

Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript

Sep 27, 2023, 4:20 PM EDT - 2 years ago

Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023

Sep 21, 2023, 8:25 PM EDT - 2 years ago

Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023

Sep 13, 2023, 8:00 AM EDT - 2 years ago

Aytu BioPharma to Present at LD Micro Main Event XVI Conference

Ironman96 Oct. 25 at 4:17 PM

$AYTU

0 · Reply

Fibonacci5 Oct. 25 at 9:50 AM

$AYTU

0 · Reply

WaspofWallStreet Oct. 23 at 4:14 PM

$AYTU ay pee u

0 · Reply

Henry20feb_ Oct. 23 at 7:26 AM

2 · Reply

Chachix Oct. 22 at 8:59 PM

0 · Reply

Alain_Simard Oct. 22 at 4:29 PM

$AYTU what ever happened to that cup and handle formation???? Lololol

0 · Reply

Henry20feb_ Oct. 22 at 7:35 AM

$AYTU "Wake Up Litlle Susie!" 🥵

0 · Reply

Butter_nutz Oct. 21 at 7:24 PM

$AYTU Corrupt management... dilution monster.... reverse split machine

0 · Reply

WaspofWallStreet Oct. 21 at 2:48 PM

$AYTU reduced position yesterday with a fill at 2.39.

0 · Reply

Henry20feb_ Oct. 19 at 2:57 PM

$AYTU My posts are not investment advice and may differ from the actual facts!

0 · Reply

Henry20feb_ Oct. 18 at 10:28 AM

$AYTU

2 · Reply

Henry20feb_ Oct. 18 at 8:45 AM

$AYTU Upside drivers: EXXUA launch; +/+ Ebitda trend; Portfolio growth; Strategic realigment; Improved Liquidity 😎

1 · Reply

Henry20feb_ Oct. 18 at 8:22 AM

$AYTU "Every descent is ultimately for the sake of a subsequent ascent".

0 · Reply

Butter_nutz Oct. 17 at 12:58 PM

$AYTU I wonder if JDs stupid and cellulite ridden wife goes to the nail salon on Wednesday midday and brags to the other women about how successful her husband is while leaving out the fact that he's a modern day corporate thief.

1 · Reply

Henry20feb_ Oct. 17 at 9:11 AM

$AYTU EXXUA

0 · Reply

Butter_nutz Oct. 15 at 1:21 AM

$AYTU Hey guys, the stock price "is what it is." JD doesn't give a rats azz about you shareholders. Dilution and RS is the name of the game here.

0 · Reply

Butter_nutz Oct. 10 at 9:00 PM

$AYTU Hope JD and his dim-witted, pedo brother have a terrible weekend. Maybe, God willing, they'll scratch the paint on their sports cars that we've bought them.

0 · Reply